CN104869991B - 防风草酸的药物组合物及其应用 - Google Patents
防风草酸的药物组合物及其应用 Download PDFInfo
- Publication number
- CN104869991B CN104869991B CN201380056583.3A CN201380056583A CN104869991B CN 104869991 B CN104869991 B CN 104869991B CN 201380056583 A CN201380056583 A CN 201380056583A CN 104869991 B CN104869991 B CN 104869991B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- application
- salt
- anisomelic acid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (27)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20125888A FI126047B (en) | 2012-08-28 | 2012-08-28 | Pharmaceutical compositions of anisomelic acid and their use |
FI20125888 | 2012-08-28 | ||
PCT/FI2013/050828 WO2014033366A1 (en) | 2012-08-28 | 2013-08-28 | Pharmaceutical compositions of anisomelic acid and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104869991A CN104869991A (zh) | 2015-08-26 |
CN104869991B true CN104869991B (zh) | 2017-12-08 |
Family
ID=49619952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380056583.3A Active CN104869991B (zh) | 2012-08-28 | 2013-08-28 | 防风草酸的药物组合物及其应用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9345687B2 (zh) |
EP (1) | EP2895162B1 (zh) |
JP (1) | JP2015530381A (zh) |
CN (1) | CN104869991B (zh) |
CA (1) | CA2922642C (zh) |
DK (1) | DK2895162T3 (zh) |
FI (1) | FI126047B (zh) |
WO (1) | WO2014033366A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9623002B2 (en) * | 2012-08-28 | 2017-04-18 | John E. Eriksson | Pharmaceutical compositions of Anisomelic acid and the use thereof |
US10196371B2 (en) * | 2014-08-17 | 2019-02-05 | Äbo Akademi | Compounds for the treatment of HPV-induced carcinoma |
FI20195527A1 (en) * | 2019-06-17 | 2020-12-18 | Aabo Akademi | Pharmaceutical compositions of Ovatodiolide and their use |
CN116600822A (zh) * | 2020-05-19 | 2023-08-15 | 吉亚生技控股股份有限公司 | 萜类化合物在治疗或预防纤维化疾病中的用途 |
US20230310369A1 (en) * | 2020-07-23 | 2023-10-05 | Arjil Biotech Holding Company Limited | Method and composition for inhibiting virus infection |
CN112964704B (zh) * | 2021-02-04 | 2024-03-22 | 甘肃润达药业有限公司 | 一种防风草内酯检测试纸、比色卡及快速检测方法 |
WO2022257086A1 (zh) * | 2021-06-10 | 2022-12-15 | 杨震 | 一种不对称合成(–)-鱼针草酸的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552389A (zh) * | 2010-12-24 | 2012-07-11 | 财团法人工业技术研究院 | 预防或治疗痛风的药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY120392A (en) * | 2000-06-08 | 2005-10-31 | Hovid Berhad | A novel drug delivery system : formulation for fat-soluble drugs |
WO2008002594A2 (en) | 2006-06-27 | 2008-01-03 | Neuroprotection For Life Corp. | Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors |
-
2012
- 2012-08-28 FI FI20125888A patent/FI126047B/en active IP Right Grant
-
2013
- 2013-08-28 JP JP2015529085A patent/JP2015530381A/ja active Pending
- 2013-08-28 EP EP13792713.3A patent/EP2895162B1/en active Active
- 2013-08-28 DK DK13792713.3T patent/DK2895162T3/en active
- 2013-08-28 CA CA2922642A patent/CA2922642C/en active Active
- 2013-08-28 CN CN201380056583.3A patent/CN104869991B/zh active Active
- 2013-08-28 US US14/423,711 patent/US9345687B2/en active Active
- 2013-08-28 WO PCT/FI2013/050828 patent/WO2014033366A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552389A (zh) * | 2010-12-24 | 2012-07-11 | 财团法人工业技术研究院 | 预防或治疗痛风的药物组合物 |
Also Published As
Publication number | Publication date |
---|---|
FI126047B (en) | 2016-06-15 |
WO2014033366A1 (en) | 2014-03-06 |
US9345687B2 (en) | 2016-05-24 |
DK2895162T3 (en) | 2018-03-26 |
CA2922642A1 (en) | 2014-03-06 |
JP2015530381A (ja) | 2015-10-15 |
EP2895162B1 (en) | 2018-01-03 |
FI20125888A (fi) | 2014-03-01 |
CN104869991A (zh) | 2015-08-26 |
CA2922642C (en) | 2021-02-23 |
US20150202180A1 (en) | 2015-07-23 |
EP2895162A1 (en) | 2015-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104869991B (zh) | 防风草酸的药物组合物及其应用 | |
Kim et al. | Apoptosis of DU145 human prostate cancer cells induced by dehydrocostus lactone isolated from the root of Saussurea lappa | |
CA2617659C (en) | Use of hydroxybenzoic acid esters and analogues for the manufacture of a medicament for the prevention and treatment of virus infection | |
JP6661800B2 (ja) | アルギン酸硫酸エステルおよびヒトパピローマウイルスによる疾患の予防および治療する薬物と健康食品の製造におけるその使用 | |
CN103037855A (zh) | 用于治疗癌症的包含视黄醇、其前体或反应产物和来自至少一种春黄菊植物的植物提取物的组合物 | |
US20220296565A1 (en) | Pharmaceutical compositions of Ovatodiolide and the use thereof | |
US8846768B2 (en) | Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia | |
Foldvari et al. | Recent progress in the application of nanotechnology for prevention and treatment of human papillomavirus infection | |
CN1708310A (zh) | 抗癌或抗病毒组合物 | |
US10959974B2 (en) | Ingenol compounds and use thereof in anti-HIV latency treatment | |
EP3072512B1 (en) | Use of new type of anti-hpv pharmaceutical preparation | |
KR101546802B1 (ko) | 붕산, 구연산, 아연, 알부민 및 비타민 c를 포함하는 파필로마 바이러스에 대한 항바이러스 피부외용제 조성물 | |
US9623002B2 (en) | Pharmaceutical compositions of Anisomelic acid and the use thereof | |
CN107207451A (zh) | 用于治疗人乳头状瘤病毒(hpv)诱导的癌症的化合物 | |
CN104725291B (zh) | Xpo1蛋白抑制剂 | |
Vidusha et al. | CYTOTOXIC EFFECTS OF BIXA ORELLANA BARK EXTRACTS ON HUMAN CELL LINE (HEPG2 CELLS) | |
WO2021234299A1 (fr) | Composition comprenant un compose ascorbo-camphorate metallique pour son utilisation dans le traitement des infections causees par papillomavirus | |
KR20140044545A (ko) | 구연산, 아연 및 l-아르기닌을 포함하는 항 바이러스제 조성물 | |
CN106038547A (zh) | Schiglautone A衍生物的组合物用于制备抗急性痛风药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200421 Address after: EBO, Finland Patentee after: Abo Akademi University Address before: Turku Co-patentee before: Pu Lisai Borrow Patentee before: John Erickson Co-patentee before: Emilia Pei Wuhu Co-patentee before: You are husky for MA Ah kappa |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220524 Address after: Turku Patentee after: Arnesen therapeutics Address before: EBO, Finland Patentee before: ABO AKADEMI University |
|
TR01 | Transfer of patent right |